化合物 T34907
| 中文名称 | 化合物 T34907 |
|---|---|
| 中文同义词 | 化合物 T34907;化合物 TP-238;N-[3-(1-吡唑基)丙基]-6-[4-[3-(二甲基氨基)丙氧基]苯基]-2-(甲砜基)嘧啶-4-胺 |
| 英文名称 | 4-Pyrimidinamine, 6-[4-[3-(dimethylamino)propoxy]phenyl]-2-(methylsulfonyl)-N-[3-(1H-pyrazol-1-yl)propyl]- |
| 英文同义词 | 4-Pyrimidinamine, 6-[4-[3-(dimethylamino)propoxy]phenyl]-2-(methylsulfonyl)-N-[3-(1H-pyrazol-1-yl)propyl]-;N-[3-(1-Pyrazolyl)propyl]-6-[4-[3-(dimethylamino)propoxy]phenyl]-2-(methylsulfonyl)pyrimidin-4-amine |
| CAS号 | 2415263-04-4 |
| 分子式 | C22H30N6O3S |
| 分子量 | 458.58 |
| EINECS号 | |
| 相关类别 | |
| Mol文件 | 2415263-04-4.mol |
| 结构式 | ![]() |
化合物 T34907 性质
| 沸点 | 702.0±70.0 °C(Predicted) |
|---|---|
| 密度 | 1.25±0.1 g/cm3(Predicted) |
| 酸度系数(pKa) | 9.25±0.28(Predicted) |
|
CECR2 7.5 (pIC 50 ) |
BPTF 6.5 (pIC 50 ) |
BRD9 5.9 (pIC 50 ) |
TP-238 (compound 4) has on target biochemical activity of 10-30 nM with CECR2 and 100-350 nM with BPTF. TP-238 shows an IC 50 of 30 nM against CECR2 and 350 nM against BPTF in an alphascreen assay. ITC shows TP-238 with a K d of 10 nM for CECR2 and 120 nM for BPTF.
